New dissolvable stent could revolutionize heart disease treatment

NCT ID NCT02890160

Completed Disease control Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a new device called Firesorb, a temporary scaffold that slowly releases medicine to keep heart arteries open and then dissolves over time. Researchers compared it to a standard permanent stent in 430 people with coronary artery disease. The goal was to see if the scaffold works as well or better at maintaining artery openness after one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Firesorb (sirolimus-eluting bioresorbable scaffold)
What this could lead to: If successful, this could offer a safer, temporary scaffold for blocked arteries that dissolves over time, potentially reducing long-term complications.
What could go wrong: This is a mid-stage trial with 430 participants, so results may not apply to everyone. The scaffold might not perform as well as permanent stents, and risks like blood clots or artery re-narrowing remain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE

Contacts and locations

Locations

Fu Wai Hospital

Beijing, Beijing Municipality, 100037, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.